| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/05/2005 | EP1492876A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules, composition, process and use thereof |
| 01/05/2005 | EP1492797A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
| 01/05/2005 | EP1492795A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 01/05/2005 | EP1492793A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/05/2005 | EP1492790A1 Imidazo fused compounds |
| 01/05/2005 | EP1492789A1 Tropane derivatives as ccr5 modulators |
| 01/05/2005 | EP1492784A2 Substituted 2,3-diphenyl pyridines |
| 01/05/2005 | EP1492779A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 01/05/2005 | EP1492778A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors |
| 01/05/2005 | EP1492777A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidase inhibitors |
| 01/05/2005 | EP1492775A2 Oxo-azabicyclic compounds |
| 01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
| 01/05/2005 | EP1492773A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 01/05/2005 | EP1492771A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 01/05/2005 | EP1492559A2 Truncated 24 kda basic fibroblast growth factor |
| 01/05/2005 | EP1492555A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell population |
| 01/05/2005 | EP1492554A2 Spherical protein particles and methods of making and using them |
| 01/05/2005 | EP1492552A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 01/05/2005 | EP1492544A1 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same |
| 01/05/2005 | EP1492542A1 Hormone replacement therapy |
| 01/05/2005 | EP1492537A1 Morpholine derivatives with a substituted acetamide group in the 2-position for use as ccr-3 antagonists for the treatment of inflammatory diseases |
| 01/05/2005 | EP1492536A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 01/05/2005 | EP1492532A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations |
| 01/05/2005 | EP1492530A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors |
| 01/05/2005 | EP1492514A1 A method for treating carrier particles and its use |
| 01/05/2005 | EP1492513A1 Hfa-suspension formulations containing an anticholinergic |
| 01/05/2005 | EP1492500A1 Formoterol and ciclesonide aerosol formulations |
| 01/05/2005 | EP1492499A1 Formoterol and mometasone aerosol formulations |
| 01/05/2005 | EP1492498A2 Hfa-suspension formulation of an anhydrate |
| 01/05/2005 | EP1248630B9 Use of a dermatological composition containing oligosaccharides for the treatment of skin diseases |
| 01/05/2005 | EP1226126B1 Pyrimidine derivatives |
| 01/05/2005 | EP1178801B1 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |
| 01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 01/05/2005 | CN1561387A Probiotic bifidobacterium strains |
| 01/05/2005 | CN1561331A Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1561224A A method of reducing mortality and morbidity associated with critical illnesses |
| 01/05/2005 | CN1561223A New drug |
| 01/05/2005 | CN1561216A Novel compounds |
| 01/05/2005 | CN1561215A Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid compounds used as nmda antagonist |
| 01/05/2005 | CN1561211A Nociceptin analogs |
| 01/05/2005 | CN1561207A Therapeutic delivery of carbon monoxide |
| 01/05/2005 | CN1561201A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 01/05/2005 | CN1561199A Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 01/05/2005 | CN1560074A Polypeptide of inhibiting crown virus and its derivant |
| 01/05/2005 | CN1560051A 取代吡唑化合物 A substituted pyrazole compound |
| 01/05/2005 | CN1560041A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/05/2005 | CN1559604A Glossy ganoderma throat fortifying tablet and its preparation method |
| 01/05/2005 | CN1559578A Chinese medicine for treating rhinitis |
| 01/05/2005 | CN1559575A Tablet medicine for treating pharyngolaryngitis and its preparation method |
| 01/05/2005 | CN1559567A Chinese medicinal preparation for treating sorethroat, aphtha and its preparation method |
| 01/05/2005 | CN1559553A Medicinal mixture for treating nasosinusitis and preparation method of its adhesive plaster |
| 01/05/2005 | CN1559527A Compound stemona cough stopping medicine and its preparation method |
| 01/05/2005 | CN1559525A Red tangerine peel medicine for treating sputum cough and its preparation method |
| 01/05/2005 | CN1559524A Medicine for treating child cough and dyspnea due to the lung-heat and its preparaton method |
| 01/05/2005 | CN1559517A Globeflover new medicinal preparation-globeflower disperstion tablet more suitable for child and aged |
| 01/05/2005 | CN1559515A Application of active component volatile oil of pummelo peel in manufacture of medicine |
| 01/05/2005 | CN1559508A Medicine for preventing and curing laryngolaryngitis and its preparation method |
| 01/05/2005 | CN1559503A Mango couth suppressing capsule and method of preparatuion long effect capsule |
| 01/05/2005 | CN1559494A Medicine for treating throat disease |
| 01/05/2005 | CN1559488A Medicinal tea of infused in boiling water and its production method |
| 01/05/2005 | CN1559485A Ganzhi syrup and preparation method |
| 01/05/2005 | CN1559481A Chinese medicine compound formula preparation for treating asthma disease |
| 01/05/2005 | CN1559480A Oral liquid for treating virus coryza and throat disease and its preparation technology |
| 01/05/2005 | CN1559462A Compound nasal drop-oil, and its prepn. method |
| 01/05/2005 | CN1559459A Traditional Chinese medicine capsule for treating tuberculosis and neo-last-cough |
| 01/05/2005 | CN1559455A Compound medicine-Re-Cuan-Ping for treating and preventing heat-stress of animals and birds |
| 01/05/2005 | CN1559451A Medicine compound having synergistic action |
| 01/05/2005 | CN1559449A Method for preparing oral liquid for treating prematophagoides farnae |
| 01/05/2005 | CN1559409A Compound prepn. contg. Brufen arginine codeine |
| 01/05/2005 | CN1559389A Levo-salbutamol sulfate inhaler, and its prepn. method |
| 01/05/2005 | CN1559387A Intravenous injection liquid of coenzyme Q10, and its prepn. method |
| 01/05/2005 | CN1183160C Human anti-factor IX/IXa antibodies |
| 01/05/2005 | CN1183157C Method for distillig active protein liquid of scorpion |
| 01/05/2005 | CN1183156C Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 01/05/2005 | CN1183122C Dipeptide nitrile cathepsin K inhibitors |
| 01/05/2005 | CN1182904C Methods for extraction and reaction using supercritical fluids |
| 01/05/2005 | CN1182840C Coated medicament forms with controlled active substance release |
| 01/04/2005 | US6839604 Compliance tracking method |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | US6838558 Useful in the treatment and control of solid tumors |
| 01/04/2005 | US6838476 Imidazoles with anti-inflammatory activity |
| 01/04/2005 | US6838472 Substituted urea retinoid agonists |
| 01/04/2005 | US6838468 4-(phenyl-piperdin-4-ylidene methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 01/04/2005 | US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 01/04/2005 | US6838456 Condensed pyridoindole derivatives |
| 01/04/2005 | US6838454 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/04/2005 | US6838441 Respiratory system diosrders in infants; administering albumin; blocking bile acids |
| 01/04/2005 | US6838439 Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/04/2005 | US6838428 A non-human mammal phenotype, vectors expressing the protein for treating respiratory system disease, viral diseases, purifying SP-D antibodies, enzyme inhibitor of metalloproteinase |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 01/04/2005 | CA2350854C 1,4-dihydropyridine derivatives and methods of producing the same |
| 12/30/2004 | US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 12/30/2004 | US20040267010 For therapy of central nervous system disorders |
| 12/30/2004 | US20040266989 Methods and compositions for the treatment of gastrointestinal disorders |
| 12/30/2004 | US20040266870 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents |
| 12/30/2004 | US20040266869 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 12/30/2004 | US20040266867 2-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-2-tert-butylaminoethanol hydrochloride; treating asthma and bronchitis |
| 12/30/2004 | US20040266861 Administering a therapeutically effective amount of a compound which is a cannabinoid receptor agonist, a pharmaceutically acceptable salt of the compound, an isomer of the compound, or a pharmaceutically acceptable salt of the isomer |